Literature DB >> 20408389

Enrollment in outpatient care among newly released prison inmates with HIV infection.

Jacques G Baillargeon1, Thomas P Giordano, Amy Jo Harzke, Gwen Baillargeon, Josiah D Rich, David P Paar.   

Abstract

OBJECTIVES: Although many prisoners infected with human immunodeficiency virus (HIV) initiate and adhere to treatment regimens while incarcerated, the benefits of in-prison therapy are frequently lost after community reentry. Little information is available on the percentage of released inmates who establish community-based HIV outpatient treatment in a timely fashion. We sought to determine the proportion of HIV-infected Texas prison inmates who enrolled in an HIV clinic within 90 days after release and to identify variables associated with timely linkage to clinical care.
METHODS: This was a retrospective cohort study of 1,750 HIV-infected inmates who were released from the Texas Department of Criminal Justice (TDCJ) and returned to Harris County between January 2004 and December 2007. We obtained demographic and clinical data from centralized databases maintained by TDCJ and the Harris County Health District, and used logistic regression analysis to identify factors associated with linkage to post-release outpatient
RESULTS: Only 20% of released inmates enrolled in an HIV clinic within 30 days of release, and only 28% did so within 90 days. Released inmates > or = 30 years of age were more likely than their younger counterparts to have enrolled in care at the 30- and 90-day time points. Inmates diagnosed with schizophrenia were more likely to have initiated care within 30 days. Inmates who received antiretroviral therapy while incarcerated and those who received enhanced discharge planning were more likely to begin care at both time points.
CONCLUSIONS: A large proportion of HIV-infected inmates fail to establish outpatient care after their release from the Texas prison system. Implementation of intensive discharge planning programs may be necessary to ensure continuity of HIV care among newly released inmates.

Entities:  

Mesh:

Year:  2010        PMID: 20408389      PMCID: PMC2788410          DOI: 10.1177/00333549101250S109

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  18 in total

1.  Predictors of post-release primary care utilization among HIV-positive prison inmates: a pilot study.

Authors:  A J Harzke; M W Ross; D P Scott
Journal:  AIDS Care       Date:  2006-05

2.  Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status.

Authors:  Terry R Barclay; Charles H Hinkin; Steven A Castellon; Karen I Mason; Matthew J Reinhard; Sarah D Marion; Andrew J Levine; Ramani S Durvasula
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

3.  Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.

Authors:  Anita Palepu; Mark W Tyndall; Keith Chan; Evan Wood; Julio S G Montaner; Robert S Hogg
Journal:  Antivir Ther       Date:  2004-10

4.  Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic.

Authors:  Christopher S Krawczyk; Ellen Funkhouser; J Michael Kilby; Richard A Kaslow; Amita K Bey; Sten H Vermund
Journal:  South Med J       Date:  2006-05       Impact factor: 0.954

5.  Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure.

Authors:  Thomas P Giordano; Fehmida Visnegarwala; A Clinton White; Catherine L Troisi; Ralph F Frankowski; Christine M Hartman; Richard M Grimes
Journal:  AIDS Care       Date:  2005-08

6.  Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care.

Authors:  Lytt I Gardner; Lisa R Metsch; Pamela Anderson-Mahoney; Anita M Loughlin; Carlos del Rio; Steffanie Strathdee; Stephanie L Sansom; Harvey A Siegal; Alan E Greenberg; Scott D Holmberg
Journal:  AIDS       Date:  2005-03-04       Impact factor: 4.177

7.  Retention in care: a challenge to survival with HIV infection.

Authors:  Thomas P Giordano; Allen L Gifford; A Clinton White; Maria E Suarez-Almazor; Linda Rabeneck; Christine Hartman; Lisa I Backus; Larry A Mole; Robert O Morgan
Journal:  Clin Infect Dis       Date:  2007-04-23       Impact factor: 9.079

8.  Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility.

Authors:  F Mostashari; E Riley; P A Selwyn; F L Altice
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-08-01

9.  Accessing antiretroviral therapy following release from prison.

Authors:  Jacques Baillargeon; Thomas P Giordano; Josiah D Rich; Z Helen Wu; Katherine Wells; Brad H Pollock; David P Paar
Journal:  JAMA       Date:  2009-02-25       Impact factor: 56.272

10.  CD4+ count-guided interruption of antiretroviral treatment.

Authors:  W M El-Sadr; J D Lundgren; J D Neaton; F Gordin; D Abrams; R C Arduino; A Babiker; W Burman; N Clumeck; C J Cohen; D Cohn; D Cooper; J Darbyshire; S Emery; G Fätkenheuer; B Gazzard; B Grund; J Hoy; K Klingman; M Losso; N Markowitz; J Neuhaus; A Phillips; C Rappoport
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

View more
  51 in total

1.  New strategies in the delivery of HIV-prevention services for minority groups in the U.S.

Authors:  Donna L Richter; Rhondette L Jones
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

2.  Predictors of reincarceration and disease progression among released HIV-infected inmates.

Authors:  Jacques Baillargeon; Thomas P Giordano; Amy Jo Harzke; Anne C Spaulding; Z Helen Wu; James J Grady; Gwen Baillargeon; David P Paar
Journal:  AIDS Patient Care STDS       Date:  2010-06       Impact factor: 5.078

3.  An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among inmates being released to the community.

Authors:  Olga Grinstead Reznick; Kathleen McCartney; Steven E Gregorich; Barry Zack; Daniel J Feaster
Journal:  J Correct Health Care       Date:  2013-05-08

Review 4.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

5.  HIV Stigma in Prisons and Jails: Results from a Staff Survey.

Authors:  Steven Belenko; Richard Dembo; Michael Copenhaver; Matthew Hiller; Holly Swan; Carmen Albizu Garcia; Daniel O'Connell; Carrie Oser; Frank Pearson; Jennifer Pankow
Journal:  AIDS Behav       Date:  2016-01

6.  Low prevalence of antiretroviral resistance among HIV type 1-positive prisoners in the Southeast United States.

Authors:  Prema Menezes; David Rosen; David A Wohl; Nichole Kiziah; Joseph Sebastian; Joseph J Eron; Becky White
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11-19       Impact factor: 2.205

7.  Improvements in Correctional HIV Services: A Case Study in Delaware.

Authors:  Holly Swan; Daniel J O'Connell; Christy A Visher; Steven S Martin; Karen R Swanson; Kristin Hernandez
Journal:  J Correct Health Care       Date:  2015-04

8.  "Seek, test, treat and retain" for hepatitis C in the United States criminal justice system.

Authors:  Sarah Larney; Curt G Beckwith; Nickolas D Zaller; Brian T Montague; Josiah Rich
Journal:  Int J Prison Health       Date:  2014

9.  Women, incarceration and HIV: a systematic review of HIV treatment access, continuity of care and health outcomes across incarceration trajectories.

Authors:  Margaret Erickson; Kate Shannon; Ariel Sernick; Neora Pick; Flo Ranville; Ruth E Martin; Andrea Krüsi
Journal:  AIDS       Date:  2019-01-27       Impact factor: 4.177

Review 10.  Correctional facilities as partners in reducing HIV disparities.

Authors:  Josiah D Rich; Ralph DiClemente; Judith Levy; Karen Lyda; Monica S Ruiz; David L Rosen; Dora Dumont
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.